In summary, we have discovered that A674563, a previously reported AKT kinase inhibitor, also demonstrates selective FLT3-ITD kinase activity over FLT3 wt in the biochemical assays, which makes it selectively potent toward FLT3-ITD positive AML cancer cell lines. Here, FLT3 is linked to cancer.